F/M Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOCU
DocuSign
DOCU
|
+$3.33M |
| 2 |
XYZ
Block Inc
XYZ
|
+$2.33M |
| 3 |
Dover
DOV
|
+$2.07M |
| 4 |
Zoetis
ZTS
|
+$2.05M |
| 5 |
Coca-Cola
KO
|
+$2.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$2.87M |
| 2 |
Revvity
RVTY
|
+$2.69M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$2.65M |
| 4 |
Qorvo
QRVO
|
+$2.25M |
| 5 |
Boeing
BA
|
+$2.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.56% |
| 2 | Consumer Discretionary | 12.3% |
| 3 | Financials | 8.98% |
| 4 | Healthcare | 8.72% |
| 5 | Industrials | 6.21% |
Similar funds
F/M Investments's Q1 2021 Portfolio in Review
As of Q1 2021, F/M Investments held 102 positions worth $127M, up 10% from $115M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
F/M Investments deployed $12M of net new capital in Q1 2021, opening 41 new positions and adding to 19 existing holdings. Its largest new stake was DocuSign: 14,369 shares worth $2.91M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $2.87M trimmed.
- F/M Investments's largest Q1 2021 buy was DocuSign: 14,369 shares worth $2.91M.
- F/M Investments added most to Repligen in Q1 2021, an estimated $1.92M increase.
- F/M Investments's biggest Q1 2021 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $2.87M.
- F/M Investments fully exited Revvity in Q1 2021, selling an estimated $2.69M.
- F/M Investments's ten largest holdings make up 46% of its $127M portfolio in Q1 2021.
- F/M Investments opened 41 new positions and closed 17 in Q1 2021.
- F/M Investments's portfolio value rose 10% quarter-over-quarter to $127M.
Based on F/M Investments's 13F filing for Q1 2021, filed 1 Jun 2021.